Drug Digest: Strategic Partnerships

In this exclusive Drug Digest video interview, Felicity Thomas, Associate Editorial Director, Pharmaceutical Technology Group, interviews experts about strategic partnerships in the bio/pharma industry. During the discussion, various experts will detail how the bio/pharma outsourcing market has evolved, how service providers have adapted to meet the shifting industry demands, the benefit of ‘integrated services’ and the potential challenge to providing such services while also being flexible, and potential trends that may shape the outsourcing market in the coming years.

Interview featuring

John McQuaid, President & Managing Director, Almac Pharma Services

John first joined Almac Group in 1994 and has held a number of management roles during his tenure. In 2011 he was appointed to Vice President of Technical Operations within Almac Pharma Services where he was responsible for overseeing the strategic growth and development of the Pharmaceutical Development & Manufacturing service offering.

John, who holds a BSc Honours degree, was promoted to President and Managing Director, Almac Pharma Services, in 2022 and is responsible for the strategic, financial and operational leadership of global business. He has extensive product development, quality assurance and validation experience with direct experience of hosting product pre-approval inspections by multiple regulatory authorities.nt. Dr. Kane received his Bachelors, Masters and PhD degrees from the Bombay College of Pharmacy, University of Bombay, India, and served as a post-doctoral fellow at the School of Pharmacy, University of Cincinnati, Ohio. He has also earned an executive MBA from Richard Ivey School of Business, University of Western Ontario, Canada. Dr. Kane is a member of various international pharmaceutical professional organizations and is often asked to speak about scientific topics on formulation, technology and other technical aspects at major industry events. He has also published many articles in international journals and delivered many talks at meetings and conferences across the globe.

Sridevi Khambhampaty, CEO at Shilpa Biologics

Dr. Sridevi Khambhampaty is presently the CEO of Shilpa Biologics. She has an impressive 20 plus-year career in the biopharmaceutical and biotechnology sector. Dr. Sridevi has a PhD from NCBS-TIFR Bangalore, and after completing a postdoctoral fellowship at Stanford University, California, she has served in various leadership roles in at Syngene International, Intas Pharmaceuticals and Dr. Reddy’s Laboratories, prior to her present assignment at Shilpa Biologics.

Sponsors

This episode of Drug Digest is sponsored by:

• Adare
• August Bioservices
• Catalent
• Coating Place
• LabVantage

About Drug Digest

Drug Digest is a tech talk video series with the Pharmaceutical Technology editors, who interview industry experts to discuss the emerging opportunities, obstacles, and advances in the pharmaceutical and biopharmaceutical industry for the research, development, formulation, analysis, upstream and downstream processing, manufacturing, supply chain, and packaging of drug products.

Upcoming episodes

• April 2025: Innovations in Biopharmaceutical Development
• May/June 2025: Solid Dosage Formulation Trends
• July/August 2025: Large-Molecule Manufacturing Trends